Retail & Wholesale » Retail | China Pioneer Pharma Holdings Ltd.

China Pioneer Pharma Holdings Ltd. | Balance Sheet

Fiscal year is January-December. All values HKD Millions.
2013
2014
2015
2016
2017
2018
Cash & Short Term Investments
1,391
986
514
427
421
281
Total Accounts Receivable
419
683
501
551
645
435
Inventories
543
775
796
583
750
502
Other Current Assets
6
69
25
11
20
17
Total Current Assets
2,359
2,514
1,835
1,572
1,836
1,235
Net Property, Plant & Equipment
22
130
91
56
63
53
Total Investments and Advances
99
178
99
122
111
238
Long-Term Note Receivable
53
115
71
174
165
77
Intangible Assets
19
251
73
18
18
16
Other Assets
3
3
3
2
3
12
Total Assets
2,558
3,194
2,175
1,951
2,202
1,640
ST Debt & Current Portion LT Debt
550
764
344
89
41
Accounts Payable
408
490
509
465
683
Income Tax Payable
9
35
19
34
20
Other Current Liabilities
64
239
55
75
71
Total Current Liabilities
1,032
1,528
926
663
815
Long-Term Debt
-
11
43
40
17
Deferred Taxes
7
51
13
1
6
Other Liabilities
34
68
-
-
-
Total Liabilities
1,075
1,661
985
712
832
Common Equity (Total)
1,483
1,409
1,191
1,239
1,369
Total Shareholders' Equity
1,483
1,409
1,191
1,239
1,369
Total Equity
1,482
1,532
1,189
1,239
1,370
Liabilities & Shareholders' Equity
2,558
3,194
2,175
1,951
2,202
Accumulated Minority Interest
-
123
2
-
1

About China Pioneer Pharma Holdings

View Profile
Address
No.15, Lane 88 Wuwei Road
Shanghai Shanghai 200331
China
Employees -
Website http://www.pioneer-pharma.com
Updated 07/08/2019
China Pioneer Pharma Holdings Ltd. is an investment company, which engages in the manufacture, promotion, and sale of pharmaceutical products. It operates through the Ophthalmic Pharmaceutical Products and Group's Pharmaceutical Products and Medical Devices Except for Ophthalmic Pharmaceutical Products segments. The Ophthalmic Pharmaceutical Products segment involves in the sales of the Group's ophthalmic pharmaceutical products to the customers under the co-promotion and channel management arrangement.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.